India’s life sciences sector: A vision for budget FY2025
Focus on enabling MSME business, expanding PLI scheme and research-linked incentives to foster API innovation and tax incentives…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
KPMG
Life sciences CEOs optimistic about company growth amid industry challenges
KPMG survey highlights sector leaders’ focus on innovation, workforce expansion, and ESG priorities
Pharma sector awaits Budget 2024 for innovation boost and regulatory reforms
Industry leaders highlight priorities ahead of Union Budget, calling for R&D incentives and reduced GST to propel growth and…
Chinese threat looms large on Indian bulk drug industry
According to Pharmexcil, the export revenues from bulk drugs in 2012-13 stood at Rs 24,698 crore which has come down to Rs 21,753…